HARLEY GROVE MEDICAL CTR.
15 HARLEY GROVE, LONDON
CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2005 | 82 | 88 | 93.2% | |
| CHD 9 | 2006 | 83 | 89 | 93.3% | |
| CHD 9 | 2007 | 85 | 92 | 92.4% | |
| CHD 9 | 2008 | 89 | 93 | 95.7% | |
| CHD 9 | 2009 | 84 | 88 | 95.5% | |
| CHD 9 | 2010 | 74 | 76 | 97.4% | |
| CHD 9 | 2011 | 72 | 74 | 97.3% | |
| CHD 9 | 2012 | 73 | 75 | 97.3% | |
| CHD 9 | 2013 | 72 | 75 | 96.0% | |
| CHD005 | 2014 | 76 | 77 | 98.7% | |
| CHD005 | 2015 | 78 | 78 | 100.0% | |
| CHD005 | 2016 | 83 | 85 | 97.6% | |
| CHD005 | 2017 | 90 | 92 | 97.8% | |
| CHD005 | 2018 | 86 | 87 | 98.9% | |
| CHD005 | 2019 | 81 | 83 | 97.6% | |
| CHD005 | 2020 | 83 | 87 | 95.4% | |
| CHD005 | 2021 | 80 | 86 | 93.0% | |
| CHD005 | 2022 | 86 | 91 | 94.5% | |
| CHD005 | 2023 | 89 | 90 | 98.9% |
